Drupal.behaviors.print = function(context) {window.print();window.close();}>
Illumina Q3 Chip Sales Fall 9 Percent, Though Exome Array Orders Spike
October 25, 2011
Illumina Q3 Chip Sales Fall 9 Percent, Though Exome Array Orders Spike
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Illumina CEO: Array Market Returned to 'Normalcy' in 2010 as BeadChip Sales Rose 10 Percent
January 18, 2011 / BioArray News
Illumina to Remain Secure if NIH Budget Shrinks as Projected, CEO Predicts
September 20, 2011 / BioArray News
Illumina's Q2 Sales Rise 36 Percent on Sequencing Demand, 'Overall Improvement' in Array Sales
August 2, 2011 / BioArray News
Illumina CEO 'Optimistic' about Array Business as Q1 Sales Spike 47 Percent
May 3, 2011 / BioArray News
Illumina Q4 Revenues Rise 45 Percent on Sequencing, Array Growth
February 15, 2011 / BioArray News